| Journal | Frontiers in pharmacology |
| Study Type | Randomized Trial |
| Population | Human participants |
Osteoarthritis affects over 32 million US adults with limited effective treatment options beyond NSAIDs and opioids, both carrying significant risks. This randomized controlled trial provides needed clinical evidence on CBD’s therapeutic potential for a condition where patients desperately seek safer alternatives.
This 60-day randomized placebo-controlled trial evaluated 45mg daily oral CBD in full-spectrum cannabis oil for osteoarthritis pain management. The study used validated outcome measures including WOMAC pain scores, VAS pain ratings, depression inventory, sleep quality index, and quality of life assessments. While the abstract appears truncated, this represents methodologically sound research examining CBD at a clinically relevant dose with comprehensive outcome measurement in a well-defined patient population.
“I’m encouraged to see rigorous trial methodology applied to CBD for osteoarthritis, as this fills a critical evidence gap I encounter daily with patients seeking alternatives to conventional pain management. The 45mg daily dose aligns with what I often observe as clinically meaningful in practice.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
FAQ
What dosage of CBD was used in this osteoarthritis study?
Patients received 45 mg of CBD daily in oral form as part of a full-spectrum cannabis oil. This dose was administered over a 60-day treatment period in a randomized controlled trial setting.
How effective was CBD for osteoarthritis pain relief?
The study measured pain intensity using the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scale as the primary outcome. While the complete results aren’t provided in this summary, the study aimed to assess CBD’s efficacy compared to placebo for managing osteoarthritis-related pain.
What other symptoms besides pain were evaluated in this CBD study?
Secondary outcomes included depression (Beck Depression Inventory), sleep quality (Pittsburgh Sleep Quality Index), pain levels (Visual Analogue Scale), and overall quality of life measures. This comprehensive approach assessed CBD’s broader impact on osteoarthritis patients’ well-being beyond just pain relief.
Is CBD safe for long-term use in osteoarthritis patients?
This study specifically monitored safety outcomes alongside efficacy over 60 days of treatment. The research was motivated partly by current pain medications’ significant side effects, suggesting CBD may offer a safer alternative, though complete safety data from this trial isn’t detailed in the provided summary.
How does CBD work for osteoarthritis symptoms?
CBD demonstrates anti-inflammatory and analgesic (pain-relieving) properties that directly target the underlying mechanisms of osteoarthritis. Since osteoarthritis is characterized as both an inflammatory and degenerative joint disease with associated chronic pain, CBD’s dual mechanism addresses both inflammation and pain pathways.